A detailed history of Tekla Capital Management LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Tekla Capital Management LLC holds 177,191 shares of MOR stock, worth $0. This represents 0.05% of its overall portfolio holdings.

Number of Shares
177,191
Previous 81,867 116.44%
Holding current value
$0
Previous $324,000 308.33%
% of portfolio
0.05%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$3.95 - $7.74 $376,529 - $737,807
95,324 Added 116.44%
177,191 $1.32 Million
Q3 2020

Nov 13, 2020

BUY
$30.28 - $35.72 $1.89 Million - $2.23 Million
62,477 Added 322.21%
81,867 $2.57 Million
Q4 2019

Feb 13, 2020

BUY
$26.07 - $36.32 $505,497 - $704,244
19,390 New
19,390 $692,000
Q3 2019

Nov 13, 2019

SELL
$24.18 - $31.58 $958,567 - $1.25 Million
-39,643 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$23.24 - $26.76 $921,303 - $1.06 Million
39,643 New
39,643 $957,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.